ActivePure Medical to Help Protect the 2021 MPCA Annual Conference
Air and Surface Purification Technology Will Outfit the Michigan Primary Care Association Annual Conference Sept. 26-28DALLAS, TX / ACCESSWIRE /...
News
Cann American Corp. Announces Revised Lease Agreement
CLOVERDALE, CA / ACCESSWIRE / September 23, 2021 / Cann American Corp. (OTC PINK:CNNA), the "Company", is pleased to announce...
Fortified Health Security Ranked as One of the Best Places to Work in 2021
Modern Healthcare's Annual Awards Program Recognizes Outstanding Employers in the Healthcare Industry on a National LevelFRANKLIN, TN / ACCESSWIRE /...
Jaguar Health Receives “Complete” Letter from FDA for Last of Four Major Technical Sections for the Company’s Application for Conditional Approval of Canalevia (Crofelemer) for Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar planning for launch of Canalevia™ for CID in dogs this DecemberCanalevia is the first and only oral plant-based prescription...
Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia
Patent strengthens and expands Viveve's intellectual property portfolio for the treatment of stress urinary incontinenceENGLEWOOD, CO / ACCESSWIRE / September...
Aytu BioPharma to Report Fourth Quarter and Full Year Fiscal 2021 Results and Provide Business Update on September 27, 2021
ENGLEWOOD, CO / ACCESSWIRE / September 23, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing...
Novamind to Present at Benzinga Healthcare Conference
Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcareTORONTO, ON / ACCESSWIRE...
Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin’s Broad-Spectrum Antiviral Properties
WAKEFIELD, MA / ACCESSWIRE / September 23, 2021 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today...
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Business Highlights
EAGAN, MN / ACCESSWIRE / September 23, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
IONIQ Sciences Announces Dr. Benjamin Haibe-Kains has Joined its Scientific Advisory Committee
SALT LAKE CITY, UT / ACCESSWIRE / September 23, 2021 / IONIQ Sciences, Inc. ("IONIQ" or the "Company"), is developing...
BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
MELVILLE, N.Y., Sept. 23, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences...
Immuron planned Acquisition of R&D Vaccine Company
MELBOURNE, Australia, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...
Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com
Consumers can subscribe for an auto-shipped supply of Tollovid Daily™ 3CL protease inhibitor for immune support every month New York,...
SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections
Analysis of subpopulations from a total of 74 patients evaluated to date from FURI includes outcomes by disease, bone and...
Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc. (Nasdaq: SRZN), a biotechnology company discovering and developing...
Scopus BioPharma to Present at the Benzinga Healthcare Small Cap Conference
Scopus to present on launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncologyNEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) --...
Ayala Pharmaceuticals Announces Publication Highlighting Clinical Activity of its Gamma Secretase Inhibitor AL101 in Desmoid Tumors
REHOVOT, Israel and WILMINGTON, Del., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company...
OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver
BETHLEHEM, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home...
Celldex Announces Upcoming Presentation of CDX-0159 Phase 1b Results in Inducible Urticaria at the 2021 European Academy of Dermatology and Venereology (EADV) 30th Congress
HAMPTON, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing symptom control...
Nexstim to Present at Redeye Medtech & Diagnostics Seminar
Press release, Helsinki, September 23, 2021 at 3 PM (EEST) Nexstim to Present at Redeye Medtech & Diagnostics Seminar Nexstim...